

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.12340644 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 7.12340644 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 7.12340644 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 7.12340644 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.12340644 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.12340644 |
| 7 | positive regulation of interferon-alpha production (GO:0032727) | 6.55391222 |
| 8 | cellular response to interferon-alpha (GO:0035457) | 6.39732309 |
| 9 | type I interferon signaling pathway (GO:0060337) | 6.33164621 |
| 10 | cellular response to type I interferon (GO:0071357) | 6.33164621 |
| 11 | response to type I interferon (GO:0034340) | 6.25417442 |
| 12 | regulation of interferon-alpha production (GO:0032647) | 6.20598435 |
| 13 | response to interferon-alpha (GO:0035455) | 5.99679436 |
| 14 | response to peptidoglycan (GO:0032494) | 5.60704786 |
| 15 | negative regulation of viral genome replication (GO:0045071) | 5.40126103 |
| 16 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.26719971 |
| 17 | response to host immune response (GO:0052572) | 5.26719971 |
| 18 | cellular response to exogenous dsRNA (GO:0071360) | 5.03499103 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.02608801 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 4.81705286 |
| 21 | positive regulation of type 2 immune response (GO:0002830) | 4.79066665 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.71482763 |
| 23 | negative regulation of interleukin-12 production (GO:0032695) | 4.67398533 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.66513508 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.66513508 |
| 26 | response to host (GO:0075136) | 4.66433913 |
| 27 | response to host defenses (GO:0052200) | 4.66433913 |
| 28 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.66433913 |
| 29 | positive regulation of interferon-beta production (GO:0032728) | 4.65931841 |
| 30 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 4.63401370 |
| 31 | neutrophil activation involved in immune response (GO:0002283) | 4.61058575 |
| 32 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.51750379 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.49834262 |
| 34 | immunoglobulin mediated immune response (GO:0016064) | 4.49463871 |
| 35 | cellular response to interferon-beta (GO:0035458) | 4.47851025 |
| 36 | cellular response to virus (GO:0098586) | 4.46353567 |
| 37 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.41521453 |
| 38 | positive regulation of T cell cytokine production (GO:0002726) | 4.40470414 |
| 39 | microglial cell activation (GO:0001774) | 4.27326553 |
| 40 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.27212361 |
| 41 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.23188034 |
| 42 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.21799110 |
| 43 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.21650730 |
| 44 | T cell migration (GO:0072678) | 4.17047991 |
| 45 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.16968699 |
| 46 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.16643598 |
| 47 | lymphocyte chemotaxis (GO:0048247) | 4.15766605 |
| 48 | negative regulation of cell killing (GO:0031342) | 4.14025892 |
| 49 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.14025892 |
| 50 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.03065687 |
| 51 | response to interferon-beta (GO:0035456) | 4.01296940 |
| 52 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.01224091 |
| 53 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.91997617 |
| 54 | natural killer cell mediated immunity (GO:0002228) | 3.91997617 |
| 55 | regulation of RIG-I signaling pathway (GO:0039535) | 3.89460025 |
| 56 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.79447926 |
| 57 | respiratory burst (GO:0045730) | 3.78182716 |
| 58 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.71052536 |
| 59 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.69969412 |
| 60 | defense response to virus (GO:0051607) | 3.68919822 |
| 61 | regulation of chemokine biosynthetic process (GO:0045073) | 3.66484201 |
| 62 | granulocyte activation (GO:0036230) | 3.64434684 |
| 63 | regulation of chronic inflammatory response (GO:0002676) | 3.61577923 |
| 64 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.59687026 |
| 65 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.51778677 |
| 66 | cellular response to interferon-gamma (GO:0071346) | 3.51772394 |
| 67 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.51500264 |
| 68 | detection of other organism (GO:0098543) | 3.50731493 |
| 69 | negative regulation of T cell mediated immunity (GO:0002710) | 3.48721552 |
| 70 | positive regulation of heat generation (GO:0031652) | 3.48151330 |
| 71 | myeloid cell activation involved in immune response (GO:0002275) | 3.45567534 |
| 72 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.42028454 |
| 73 | defense response to protozoan (GO:0042832) | 3.41764035 |
| 74 | reactive oxygen species biosynthetic process (GO:1903409) | 3.35798885 |
| 75 | regulation of T cell cytokine production (GO:0002724) | 3.35455426 |
| 76 | regulation of fever generation (GO:0031620) | 3.35416213 |
| 77 | response to protozoan (GO:0001562) | 3.34302532 |
| 78 | regulation of interferon-beta production (GO:0032648) | 3.34045807 |
| 79 | response to muramyl dipeptide (GO:0032495) | 3.33649735 |
| 80 | germinal center formation (GO:0002467) | 3.33377606 |
| 81 | T-helper 1 type immune response (GO:0042088) | 3.33205686 |
| 82 | positive regulation of interleukin-12 production (GO:0032735) | 3.32572038 |
| 83 | B cell mediated immunity (GO:0019724) | 3.30927969 |
| 84 | regulation of mononuclear cell migration (GO:0071675) | 3.30319672 |
| 85 | regulation of gamma-delta T cell activation (GO:0046643) | 3.30061239 |
| 86 | macrophage activation (GO:0042116) | 3.29943799 |
| 87 | positive regulation of interleukin-17 production (GO:0032740) | 3.29681835 |
| 88 | detection of bacterium (GO:0016045) | 3.29349164 |
| 89 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.28227897 |
| 90 | regulation of T cell tolerance induction (GO:0002664) | 3.28017332 |
| 91 | eosinophil chemotaxis (GO:0048245) | 3.25449179 |
| 92 | neutrophil activation (GO:0042119) | 3.24272992 |
| 93 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.24158252 |
| 94 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.23819463 |
| 95 | regulation of interleukin-17 production (GO:0032660) | 3.21332503 |
| 96 | negative regulation of viral process (GO:0048525) | 3.20500522 |
| 97 | regulation of viral genome replication (GO:0045069) | 3.17355955 |
| 98 | response to interferon-gamma (GO:0034341) | 3.17183010 |
| 99 | I-kappaB phosphorylation (GO:0007252) | 3.16150746 |
| 100 | positive regulation of antigen processing and presentation (GO:0002579) | 3.15393343 |
| 101 | negative regulation of interleukin-17 production (GO:0032700) | 3.13877280 |
| 102 | positive regulation of lymphocyte migration (GO:2000403) | 3.13574694 |
| 103 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.12880147 |
| 104 | regulation of interleukin-12 production (GO:0032655) | 3.11682651 |
| 105 | NIK/NF-kappaB signaling (GO:0038061) | 3.10860677 |
| 106 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.10265872 |
| 107 | superoxide anion generation (GO:0042554) | 3.08849349 |
| 108 | myeloid dendritic cell differentiation (GO:0043011) | 3.08383749 |
| 109 | monocyte chemotaxis (GO:0002548) | 3.07667000 |
| 110 | negative regulation of type 2 immune response (GO:0002829) | 3.06494911 |
| 111 | detection of molecule of bacterial origin (GO:0032490) | 3.05717202 |
| 112 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.05376695 |
| 113 | positive regulation of defense response to virus by host (GO:0002230) | 3.04898532 |
| 114 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.02946527 |
| 115 | detection of external biotic stimulus (GO:0098581) | 3.02804886 |
| 116 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.02804281 |
| 117 | regulation of antigen processing and presentation (GO:0002577) | 3.02697192 |
| 118 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.99305134 |
| 119 | regulation of tolerance induction (GO:0002643) | 2.98893164 |
| 120 | response to exogenous dsRNA (GO:0043330) | 2.98730009 |
| 121 | regulation of vitamin metabolic process (GO:0030656) | 2.96586414 |
| 122 | negative regulation of type I interferon production (GO:0032480) | 2.96143288 |
| 123 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.94289641 |
| 124 | regulation of defense response to virus by host (GO:0050691) | 2.93623927 |
| 125 | natural killer cell activation involved in immune response (GO:0002323) | 2.92906551 |
| 126 | positive regulation of chemokine production (GO:0032722) | 2.90461654 |
| 127 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.89878972 |
| 128 | negative regulation of innate immune response (GO:0045824) | 2.88395227 |
| 129 | interferon-gamma secretion (GO:0072643) | 2.88378191 |
| 130 | leukocyte mediated cytotoxicity (GO:0001909) | 2.87510937 |
| 131 | regulation of T-helper cell differentiation (GO:0045622) | 2.86585059 |
| 132 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.86167269 |
| 133 | eosinophil migration (GO:0072677) | 2.85883043 |
| 134 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.85271932 |
| 135 | regulation of type 2 immune response (GO:0002828) | 2.83913896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 9.38857032 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 8.08053429 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 7.66595798 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.69623264 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.72197260 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.51212155 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 3.93419412 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.65259349 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.58885354 |
| 10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.56587888 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.17259609 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.00769724 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.86588875 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.72274692 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.60942800 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.46284875 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.39335803 |
| 18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.21514416 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.21358412 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.01753892 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.68804257 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.68269817 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.67537035 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.55613864 |
| 25 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54118229 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.49670911 |
| 27 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47492648 |
| 28 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44024442 |
| 29 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.42490373 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 1.37184316 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36144589 |
| 32 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34881842 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34269063 |
| 34 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32094747 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.27929826 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.26317934 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.25358803 |
| 38 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21953681 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.20448520 |
| 40 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.17291886 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.17279811 |
| 42 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.15296018 |
| 43 | MAF_26560356_Chip-Seq_TH1_Human | 1.13631090 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.13147688 |
| 45 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12974257 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12872139 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.12843138 |
| 48 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11900768 |
| 49 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11205345 |
| 50 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.09981820 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09321972 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07930277 |
| 53 | MYB_26560356_Chip-Seq_TH1_Human | 1.05387628 |
| 54 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.04791300 |
| 55 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.04015765 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01594985 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01567314 |
| 58 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.01003876 |
| 59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00775951 |
| 60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.98380547 |
| 61 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97476270 |
| 62 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.97078654 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96868769 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96737884 |
| 65 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94279599 |
| 66 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.93190542 |
| 67 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92198474 |
| 68 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91024789 |
| 69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90381335 |
| 70 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.85919859 |
| 71 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84568315 |
| 72 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84302173 |
| 73 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84302173 |
| 74 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83296436 |
| 75 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82585691 |
| 76 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.80838442 |
| 77 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79765416 |
| 78 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78988629 |
| 79 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.75297930 |
| 80 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.74917667 |
| 81 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74865640 |
| 82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73665659 |
| 83 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.72761134 |
| 84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.72486344 |
| 85 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.71500099 |
| 86 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69520881 |
| 87 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.69199739 |
| 88 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69043782 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.68421652 |
| 90 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.67424390 |
| 91 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.66211917 |
| 92 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.65773246 |
| 93 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.65281071 |
| 94 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.65002652 |
| 95 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.64419253 |
| 96 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.64412562 |
| 97 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.64290615 |
| 98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64246992 |
| 99 | UTX_26944678_Chip-Seq_JUKART_Human | 0.63864494 |
| 100 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.63794063 |
| 101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.62807166 |
| 102 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62540305 |
| 103 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.59799497 |
| 104 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.58906236 |
| 105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.57615341 |
| 106 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55386476 |
| 107 | MAF_26560356_Chip-Seq_TH2_Human | 0.54751841 |
| 108 | CJUN_26792858_Chip-Seq_BT549_Human | 0.52756944 |
| 109 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.52625860 |
| 110 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.52495980 |
| 111 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.50437202 |
| 112 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.50017470 |
| 113 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.49760067 |
| 114 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.49065929 |
| 115 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.48648509 |
| 116 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.46835297 |
| 117 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.46403764 |
| 118 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.44701401 |
| 119 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.44247550 |
| 120 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.43674662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009785_altered_susceptibility_to | 4.58376264 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.33530658 |
| 3 | MP0006082_CNS_inflammation | 4.02830838 |
| 4 | MP0003724_increased_susceptibility_to | 4.00004333 |
| 5 | MP0003303_peritoneal_inflammation | 3.80028408 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.70511390 |
| 7 | MP0003436_decreased_susceptibility_to | 3.65597895 |
| 8 | MP0004510_myositis | 3.29193854 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.27348864 |
| 10 | MP0005025_abnormal_response_to | 3.22690696 |
| 11 | MP0001790_abnormal_immune_system | 3.12395489 |
| 12 | MP0005387_immune_system_phenotype | 3.12395489 |
| 13 | MP0002419_abnormal_innate_immunity | 2.98840075 |
| 14 | MP0000685_abnormal_immune_system | 2.84049290 |
| 15 | MP0005671_abnormal_response_to | 2.54039489 |
| 16 | MP0002723_abnormal_immune_serum | 2.53132096 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.52374849 |
| 18 | MP0001800_abnormal_humoral_immune | 2.51232119 |
| 19 | MP0004858_abnormal_nervous_system | 2.42635862 |
| 20 | MP0005058_abnormal_lysosome_morphology | 2.40313307 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.37198275 |
| 22 | MP0009764_decreased_sensitivity_to | 2.23443175 |
| 23 | MP0004947_skin_inflammation | 2.21882531 |
| 24 | MP0001819_abnormal_immune_cell | 2.09588174 |
| 25 | MP0003075_altered_response_to | 2.03082615 |
| 26 | MP0000604_amyloidosis | 2.02704778 |
| 27 | MP0002420_abnormal_adaptive_immunity | 2.00934779 |
| 28 | MP0005451_abnormal_body_composition | 2.00526684 |
| 29 | MP0008469_abnormal_protein_level | 1.94714986 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.87785668 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.85615135 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.84725585 |
| 33 | MP0001853_heart_inflammation | 1.82553428 |
| 34 | MP0003448_altered_tumor_morphology | 1.82347656 |
| 35 | MP0009278_abnormal_bone_marrow | 1.75247465 |
| 36 | MP0000343_altered_response_to | 1.74806146 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.63855882 |
| 38 | MP0005167_abnormal_blood-brain_barrier | 1.61139852 |
| 39 | MP0002006_tumorigenesis | 1.60186406 |
| 40 | MP0009840_abnormal_foam_cell | 1.51628935 |
| 41 | MP0008004_abnormal_stomach_pH | 1.49547192 |
| 42 | MP0000716_abnormal_immune_system | 1.45011395 |
| 43 | MP0005164_abnormal_response_to | 1.44571838 |
| 44 | MP0002405_respiratory_system_inflammati | 1.42134806 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.40336695 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.40336695 |
| 47 | MP0004782_abnormal_surfactant_physiolog | 1.40069361 |
| 48 | MP0005310_abnormal_salivary_gland | 1.37493541 |
| 49 | MP0002998_abnormal_bone_remodeling | 1.37181717 |
| 50 | MP0005166_decreased_susceptibility_to | 1.34656048 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.34620209 |
| 52 | MP0002398_abnormal_bone_marrow | 1.33475520 |
| 53 | MP0010307_abnormal_tumor_latency | 1.28415409 |
| 54 | MP0002139_abnormal_hepatobiliary_system | 1.27554396 |
| 55 | MP0001501_abnormal_sleep_pattern | 1.26493107 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.26207588 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.25822778 |
| 58 | MP0003690_abnormal_glial_cell | 1.22992318 |
| 59 | MP0006054_spinal_hemorrhage | 1.14372981 |
| 60 | MP0003186_abnormal_redox_activity | 1.12488716 |
| 61 | MP0002429_abnormal_blood_cell | 1.11769710 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.10787670 |
| 63 | MP0000858_altered_metastatic_potential | 1.09874990 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 1.09066782 |
| 65 | MP0009763_increased_sensitivity_to | 1.08153952 |
| 66 | MP0003300_gastrointestinal_ulcer | 1.07291248 |
| 67 | MP0003329_amyloid_beta_deposits | 1.02889406 |
| 68 | MP0005390_skeleton_phenotype | 1.00900572 |
| 69 | MP0003195_calcinosis | 1.00003395 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 0.99809455 |
| 71 | MP0000689_abnormal_spleen_morphology | 0.98296818 |
| 72 | MP0003183_abnormal_peptide_metabolism | 0.96662809 |
| 73 | MP0002332_abnormal_exercise_endurance | 0.92398289 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 0.89329809 |
| 75 | MP0002722_abnormal_immune_system | 0.87596636 |
| 76 | MP0003866_abnormal_defecation | 0.85452105 |
| 77 | MP0001542_abnormal_bone_strength | 0.81348666 |
| 78 | MP0000703_abnormal_thymus_morphology | 0.81112599 |
| 79 | MP0003091_abnormal_cell_migration | 0.77203433 |
| 80 | MP0005083_abnormal_biliary_tract | 0.76565092 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 0.75974656 |
| 82 | MP0008260_abnormal_autophagy | 0.75285495 |
| 83 | MP0001663_abnormal_digestive_system | 0.75069709 |
| 84 | MP0003646_muscle_fatigue | 0.73436127 |
| 85 | MP0001851_eye_inflammation | 0.72354960 |
| 86 | MP0008874_decreased_physiological_sensi | 0.72017245 |
| 87 | MP0002132_abnormal_respiratory_system | 0.71506581 |
| 88 | MP0003221_abnormal_cardiomyocyte_apopto | 0.67613265 |
| 89 | MP0003045_fibrosis | 0.67269908 |
| 90 | MP0001873_stomach_inflammation | 0.65597033 |
| 91 | MP0000249_abnormal_blood_vessel | 0.65078629 |
| 92 | MP0010386_abnormal_urinary_bladder | 0.64487448 |
| 93 | MP0001881_abnormal_mammary_gland | 0.62557216 |
| 94 | MP0002693_abnormal_pancreas_physiology | 0.62300640 |
| 95 | MP0005165_increased_susceptibility_to | 0.60400896 |
| 96 | MP0002933_joint_inflammation | 0.60384010 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.58975463 |
| 98 | MP0005319_abnormal_enzyme/_coenzyme | 0.58891044 |
| 99 | MP0003763_abnormal_thymus_physiology | 0.57606441 |
| 100 | MP0005535_abnormal_body_temperature | 0.57318688 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.56137249 |
| 102 | MP0008775_abnormal_heart_ventricle | 0.56057416 |
| 103 | MP0002254_reproductive_system_inflammat | 0.56050376 |
| 104 | MP0000609_abnormal_liver_physiology | 0.54974674 |
| 105 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.51812305 |
| 106 | MP0000569_abnormal_digit_pigmentation | 0.51434467 |
| 107 | MP0002090_abnormal_vision | 0.49781993 |
| 108 | MP0004808_abnormal_hematopoietic_stem | 0.49588366 |
| 109 | MP0003795_abnormal_bone_structure | 0.49081721 |
| 110 | MP0005076_abnormal_cell_differentiation | 0.48873255 |
| 111 | MP0009765_abnormal_xenobiotic_induced | 0.48535756 |
| 112 | MP0004883_abnormal_blood_vessel | 0.46788206 |
| 113 | MP0001958_emphysema | 0.46273094 |
| 114 | MP0000920_abnormal_myelination | 0.45797018 |
| 115 | MP0005023_abnormal_wound_healing | 0.45485075 |
| 116 | MP0003828_pulmonary_edema | 0.45245701 |
| 117 | MP0010352_gastrointestinal_tract_polyps | 0.44368598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.68315791 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.53892367 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.41478478 |
| 4 | Autoimmune thrombocytopenia (HP:0001973) | 6.07421293 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.60127955 |
| 6 | Increased IgM level (HP:0003496) | 5.35174023 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.17940345 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.09151641 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 5.05098313 |
| 10 | Basal ganglia calcification (HP:0002135) | 4.46143172 |
| 11 | Chronic otitis media (HP:0000389) | 4.39780747 |
| 12 | Stomatitis (HP:0010280) | 4.21486098 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 4.18059386 |
| 14 | Vasculitis (HP:0002633) | 4.05113855 |
| 15 | Recurrent skin infections (HP:0001581) | 3.95813466 |
| 16 | Orchitis (HP:0100796) | 3.90219248 |
| 17 | Keratoconjunctivitis (HP:0001096) | 3.89700450 |
| 18 | Tetraparesis (HP:0002273) | 3.87658469 |
| 19 | Myositis (HP:0100614) | 3.79563777 |
| 20 | Gingivitis (HP:0000230) | 3.78574012 |
| 21 | Increased cerebral lipofuscin (HP:0011813) | 3.75589161 |
| 22 | Hypergammaglobulinemia (HP:0010702) | 3.72521947 |
| 23 | Recurrent viral infections (HP:0004429) | 3.68061190 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.61540437 |
| 25 | Vacuolated lymphocytes (HP:0001922) | 3.60915641 |
| 26 | Optic neuritis (HP:0100653) | 3.57804415 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 3.57804415 |
| 28 | Recurrent fungal infections (HP:0002841) | 3.52186579 |
| 29 | Prostate neoplasm (HP:0100787) | 3.51842523 |
| 30 | Porencephaly (HP:0002132) | 3.48302615 |
| 31 | Interstitial pulmonary disease (HP:0006530) | 3.37682583 |
| 32 | Encephalitis (HP:0002383) | 3.21536896 |
| 33 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.16606343 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 3.16057766 |
| 35 | Obstructive lung disease (HP:0006536) | 3.16057766 |
| 36 | Nasal polyposis (HP:0100582) | 3.13634148 |
| 37 | Abnormality of T cell number (HP:0011839) | 3.04283662 |
| 38 | T lymphocytopenia (HP:0005403) | 3.02744594 |
| 39 | Thick nail (HP:0001805) | 3.02204555 |
| 40 | Autoimmune hemolytic anemia (HP:0001890) | 2.98598570 |
| 41 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.95918332 |
| 42 | Periodontitis (HP:0000704) | 2.94136209 |
| 43 | Pulmonary infiltrates (HP:0002113) | 2.88565521 |
| 44 | Abnormality of the nasal mucosa (HP:0000433) | 2.87674477 |
| 45 | Gangrene (HP:0100758) | 2.84804365 |
| 46 | Axonal loss (HP:0003447) | 2.84299455 |
| 47 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.82325480 |
| 48 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.82325480 |
| 49 | Abnormality of glycolipid metabolism (HP:0010969) | 2.82325480 |
| 50 | Pustule (HP:0200039) | 2.81049353 |
| 51 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.76305888 |
| 52 | Recurrent cutaneous fungal infections (HP:0011370) | 2.76305888 |
| 53 | Poor head control (HP:0002421) | 2.70783981 |
| 54 | Urticaria (HP:0001025) | 2.69453809 |
| 55 | Premature loss of primary teeth (HP:0006323) | 2.67160270 |
| 56 | Increased IgE level (HP:0003212) | 2.66658247 |
| 57 | Chronic sinusitis (HP:0011109) | 2.65605511 |
| 58 | Recurrent bronchitis (HP:0002837) | 2.62460027 |
| 59 | Disinhibition (HP:0000734) | 2.61666889 |
| 60 | Esophageal neoplasm (HP:0100751) | 2.60343499 |
| 61 | Neoplasm of head and neck (HP:0012288) | 2.60343499 |
| 62 | Cellulitis (HP:0100658) | 2.58016726 |
| 63 | Peritonitis (HP:0002586) | 2.57917075 |
| 64 | Cleft eyelid (HP:0000625) | 2.56517137 |
| 65 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.53281894 |
| 66 | Recurrent pneumonia (HP:0006532) | 2.45347929 |
| 67 | Pulmonary embolism (HP:0002204) | 2.43255497 |
| 68 | Lower limb hyperreflexia (HP:0002395) | 2.41088437 |
| 69 | Dysostosis multiplex (HP:0000943) | 2.38577310 |
| 70 | Hematochezia (HP:0002573) | 2.38442876 |
| 71 | Recurrent lower respiratory tract infections (HP:0002783) | 2.38280350 |
| 72 | Petechiae (HP:0000967) | 2.36731546 |
| 73 | Purpura (HP:0000979) | 2.35686458 |
| 74 | Gingival bleeding (HP:0000225) | 2.34520014 |
| 75 | Hepatosplenomegaly (HP:0001433) | 2.33934303 |
| 76 | Episodic fever (HP:0001954) | 2.32913807 |
| 77 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.32480318 |
| 78 | Joint swelling (HP:0001386) | 2.31785006 |
| 79 | Loss of speech (HP:0002371) | 2.30997983 |
| 80 | Chest pain (HP:0100749) | 2.29409872 |
| 81 | Abnormality of the endocardium (HP:0004306) | 2.29100551 |
| 82 | Leukocytosis (HP:0001974) | 2.28661517 |
| 83 | Glomerulonephritis (HP:0000099) | 2.27725641 |
| 84 | Polyneuropathy (HP:0001271) | 2.27707583 |
| 85 | Amyloidosis (HP:0011034) | 2.27366997 |
| 86 | Vertigo (HP:0002321) | 2.25985847 |
| 87 | Spontaneous hematomas (HP:0007420) | 2.25639747 |
| 88 | Colitis (HP:0002583) | 2.23192066 |
| 89 | Osteomyelitis (HP:0002754) | 2.22626498 |
| 90 | Vertebral compression fractures (HP:0002953) | 2.22019209 |
| 91 | Bone pain (HP:0002653) | 2.21344069 |
| 92 | Abnormality of the pericardium (HP:0001697) | 2.21066837 |
| 93 | Gastrointestinal infarctions (HP:0005244) | 2.20675691 |
| 94 | Abnormality of B cell number (HP:0010975) | 2.19976027 |
| 95 | Abnormality of T cells (HP:0002843) | 2.19558886 |
| 96 | Nephritis (HP:0000123) | 2.19490840 |
| 97 | Pathologic fracture (HP:0002756) | 2.16781411 |
| 98 | Spastic tetraparesis (HP:0001285) | 2.15954055 |
| 99 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.15822632 |
| 100 | Mucopolysacchariduria (HP:0008155) | 2.15822632 |
| 101 | Prolonged bleeding time (HP:0003010) | 2.15370848 |
| 102 | Meningitis (HP:0001287) | 2.15108477 |
| 103 | Plagiocephaly (HP:0001357) | 2.14755239 |
| 104 | Granulocytopenia (HP:0001913) | 2.14666243 |
| 105 | Hemoptysis (HP:0002105) | 2.14596424 |
| 106 | Acne (HP:0001061) | 2.13185815 |
| 107 | Abnormality of iron homeostasis (HP:0011031) | 2.12984484 |
| 108 | Arterial thrombosis (HP:0004420) | 2.12692140 |
| 109 | Inflammation of the large intestine (HP:0002037) | 2.10840610 |
| 110 | Progressive neurologic deterioration (HP:0002344) | 2.09990684 |
| 111 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.09813572 |
| 112 | Osteolytic defects of the hand bones (HP:0009699) | 2.09813572 |
| 113 | Keratitis (HP:0000491) | 2.08922677 |
| 114 | Increased serum ferritin (HP:0003281) | 2.08869349 |
| 115 | Myocardial infarction (HP:0001658) | 2.08731967 |
| 116 | Glomerulopathy (HP:0100820) | 2.08246230 |
| 117 | Progressive visual loss (HP:0000529) | 2.05881426 |
| 118 | Epistaxis (HP:0000421) | 2.05698050 |
| 119 | Abnormality of the basal ganglia (HP:0002134) | 2.03816770 |
| 120 | Gastrointestinal inflammation (HP:0004386) | 2.03399797 |
| 121 | Hypertensive crisis (HP:0100735) | 2.02813340 |
| 122 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.00820932 |
| 123 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.00820932 |
| 124 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.00820932 |
| 125 | Abnormality of the peritoneum (HP:0002585) | 2.00377823 |
| 126 | Abnormality of the pleura (HP:0002103) | 1.96921708 |
| 127 | Anorexia (HP:0002039) | 1.94532409 |
| 128 | Hemorrhage of the eye (HP:0011885) | 1.94374179 |
| 129 | Arthralgia (HP:0002829) | 1.94082265 |
| 130 | Keratoconjunctivitis sicca (HP:0001097) | 1.93518630 |
| 131 | Eosinophilia (HP:0001880) | 1.91534684 |
| 132 | Skin ulcer (HP:0200042) | 1.90861376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 5.05169816 |
| 2 | TYK2 | 4.30930397 |
| 3 | TBK1 | 4.22451301 |
| 4 | MAP3K14 | 4.19919805 |
| 5 | RIPK4 | 3.89876720 |
| 6 | IKBKE | 3.86321156 |
| 7 | IRAK4 | 3.22253876 |
| 8 | BLK | 2.82405150 |
| 9 | JAK3 | 2.75283208 |
| 10 | JAK1 | 2.68375869 |
| 11 | MAP3K13 | 2.66437169 |
| 12 | IRAK3 | 2.59522480 |
| 13 | PRPF4B | 2.58447505 |
| 14 | KIT | 2.40081620 |
| 15 | PIM2 | 2.29419659 |
| 16 | ERN1 | 2.24413424 |
| 17 | IKBKB | 2.16236023 |
| 18 | ARAF | 2.09425045 |
| 19 | TAOK2 | 1.89656896 |
| 20 | MAP2K3 | 1.80006828 |
| 21 | FGFR4 | 1.63900075 |
| 22 | TXK | 1.60733483 |
| 23 | CSK | 1.59201292 |
| 24 | MAP4K1 | 1.52729516 |
| 25 | BMPR2 | 1.51877007 |
| 26 | MATK | 1.48052989 |
| 27 | MAP3K3 | 1.44862191 |
| 28 | TAOK1 | 1.41687636 |
| 29 | MAP3K5 | 1.36244923 |
| 30 | FGR | 1.32300329 |
| 31 | SYK | 1.31382752 |
| 32 | IRAK1 | 1.26872137 |
| 33 | DDR2 | 1.21466482 |
| 34 | ZAP70 | 1.19489932 |
| 35 | CHUK | 1.16428678 |
| 36 | BMX | 1.16031314 |
| 37 | MAP3K9 | 1.14552667 |
| 38 | HCK | 1.14006883 |
| 39 | NME2 | 1.11042063 |
| 40 | MST4 | 1.09819527 |
| 41 | TNK2 | 1.09511468 |
| 42 | IRAK2 | 1.09067957 |
| 43 | ABL2 | 1.08396479 |
| 44 | FGFR3 | 1.07134805 |
| 45 | CDC42BPA | 1.06228076 |
| 46 | EPHB1 | 1.05087785 |
| 47 | MARK3 | 1.04269080 |
| 48 | RPS6KA4 | 1.03205033 |
| 49 | JAK2 | 1.01586181 |
| 50 | EIF2AK2 | 0.99639978 |
| 51 | LYN | 0.94834784 |
| 52 | EPHA3 | 0.93206981 |
| 53 | LCK | 0.88846108 |
| 54 | KSR2 | 0.87543715 |
| 55 | TAOK3 | 0.86719817 |
| 56 | FES | 0.86468216 |
| 57 | MST1R | 0.82330125 |
| 58 | NEK9 | 0.77808425 |
| 59 | SIK3 | 0.77423490 |
| 60 | PIM1 | 0.72922389 |
| 61 | ITK | 0.72759155 |
| 62 | GRK6 | 0.71429447 |
| 63 | CLK1 | 0.71393455 |
| 64 | PLK2 | 0.69115672 |
| 65 | STK4 | 0.65432020 |
| 66 | MOS | 0.63752675 |
| 67 | DAPK2 | 0.63617285 |
| 68 | PRKCD | 0.61522182 |
| 69 | MAP3K1 | 0.59652118 |
| 70 | EGFR | 0.58979269 |
| 71 | CSF1R | 0.56317436 |
| 72 | MAP3K12 | 0.53504755 |
| 73 | ABL1 | 0.52403047 |
| 74 | PRKCQ | 0.50462720 |
| 75 | TRIB3 | 0.48603323 |
| 76 | DAPK3 | 0.47990610 |
| 77 | MAPK7 | 0.47475926 |
| 78 | GRK7 | 0.46814593 |
| 79 | BTK | 0.45036521 |
| 80 | DYRK3 | 0.44276857 |
| 81 | SIK2 | 0.42576050 |
| 82 | CDK6 | 0.40428768 |
| 83 | ERBB3 | 0.39329744 |
| 84 | RIPK1 | 0.36760314 |
| 85 | MAP2K6 | 0.36723203 |
| 86 | MAP3K11 | 0.35679710 |
| 87 | TESK2 | 0.35194202 |
| 88 | RAF1 | 0.34537572 |
| 89 | BRAF | 0.34291242 |
| 90 | MAP3K6 | 0.33811362 |
| 91 | TYRO3 | 0.32066493 |
| 92 | PDPK1 | 0.31628464 |
| 93 | CDK4 | 0.31554249 |
| 94 | YES1 | 0.31134828 |
| 95 | TEC | 0.30982168 |
| 96 | NLK | 0.30307907 |
| 97 | PRKD2 | 0.30155358 |
| 98 | FYN | 0.29666330 |
| 99 | STK3 | 0.29596594 |
| 100 | STK10 | 0.29528296 |
| 101 | RPS6KL1 | 0.27961443 |
| 102 | RPS6KC1 | 0.27961443 |
| 103 | MARK2 | 0.27773484 |
| 104 | ERBB4 | 0.25878694 |
| 105 | ADRBK2 | 0.25435878 |
| 106 | STK24 | 0.24796366 |
| 107 | PIK3CG | 0.24557392 |
| 108 | MAP3K10 | 0.24099094 |
| 109 | RPS6KA5 | 0.23246857 |
| 110 | PRKG2 | 0.22602759 |
| 111 | PDK1 | 0.22387326 |
| 112 | TRPM7 | 0.20544692 |
| 113 | MAPK4 | 0.20369373 |
| 114 | MAPK11 | 0.20366018 |
| 115 | RPS6KA6 | 0.20336991 |
| 116 | MAPK3 | 0.19286524 |
| 117 | PRKCE | 0.18893150 |
| 118 | SGK1 | 0.16964769 |
| 119 | TGFBR2 | 0.16814426 |
| 120 | IGF1R | 0.15859048 |
| 121 | MAPKAPK2 | 0.15747386 |
| 122 | SRC | 0.15576425 |
| 123 | BMPR1B | 0.14797630 |
| 124 | TESK1 | 0.14179502 |
| 125 | INSR | 0.13632532 |
| 126 | NTRK1 | 0.11043103 |
| 127 | GRK5 | 0.09923126 |
| 128 | ALK | 0.08577591 |
| 129 | HIPK2 | 0.08491322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.50633068 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.49869551 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.29643408 |
| 4 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 3.24287306 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.02156494 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.86396253 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.68548334 |
| 8 | Influenza A_Homo sapiens_hsa05164 | 2.63025924 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.52924337 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.50761704 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.38088987 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.35810612 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 2.31705721 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.30419764 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.24356734 |
| 16 | Asthma_Homo sapiens_hsa05310 | 2.19131816 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.18602863 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 2.12559286 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.08626639 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.05715186 |
| 21 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.01773281 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.01285121 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.99905087 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.78885493 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.64808807 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63063670 |
| 27 | Salmonella infection_Homo sapiens_hsa05132 | 1.62359708 |
| 28 | Hepatitis C_Homo sapiens_hsa05160 | 1.51929992 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.45014218 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.39823870 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36576103 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.31199605 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.27128862 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.26894477 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.21973897 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.21212469 |
| 37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19980026 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.18710621 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.18653837 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.12218303 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.11482787 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09409893 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.04442438 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.04121028 |
| 45 | Prion diseases_Homo sapiens_hsa05020 | 0.97814335 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94813036 |
| 47 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.92132721 |
| 48 | Amoebiasis_Homo sapiens_hsa05146 | 0.86623419 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84534709 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.77656653 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77420887 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76380149 |
| 53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74795920 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72783388 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71900742 |
| 56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70482788 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64905134 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62818059 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58241647 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.53303552 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 0.51630691 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51587483 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 0.50302871 |
| 64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49826539 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49537432 |
| 66 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47761093 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46689578 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44638199 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43808695 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43168517 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42250072 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40597875 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.40397605 |
| 74 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37802223 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35095218 |
| 76 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34740795 |
| 77 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.34489794 |
| 78 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.34156754 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.33893684 |
| 80 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.33371439 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32888150 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.31512742 |
| 83 | Proteasome_Homo sapiens_hsa03050 | 0.29477296 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28593524 |
| 85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.28541225 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28294692 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24485123 |
| 88 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.24266094 |
| 89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.23783392 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23572224 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.20185155 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19505716 |
| 93 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.19332677 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.18604060 |
| 95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.17455564 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.15662156 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.14222127 |
| 98 | Prostate cancer_Homo sapiens_hsa05215 | 0.11456764 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.10652688 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.10066335 |
| 101 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.09897250 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.08230230 |
| 103 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.07227541 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.07183360 |
| 105 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.06691077 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.06005455 |
| 107 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.05913837 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.05235976 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.05072113 |
| 110 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.04772778 |
| 111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.04510791 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.03281416 |
| 113 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.02897954 |

